TangNLiDWangXSunZ. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844-847.
2.
ShakooryBCarcilloJAChathamWW, et al. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med. 2016;44:275-281.
3.
RussellBMossCGeorgeG, et al. Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence. Ecancermedicalscience. 2020;14:1022.
4.
LuXZhangLDuH, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382:1663-1665.
5.
ZhouFYuTDuR, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062.
6.
WangDHuBHuC, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069.
7.
XuYLiXZhuB, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26:502-505.
8.
ChenGWuDGuoW, et al. Clinical and immunologic features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620-2629.